Evidence map›Paper›PMID 30581136›Full record

ArticleCell chemical biology2019

14-Helical β-Peptides Elicit Toxicity against C. albicans by Forming Pores in the Cell Membrane and Subsequently Disrupting Intracellular Organelles.

Myung-Ryul Lee, Namrata Raman, Patricia Ortiz-Bermúdez, David M Lynn, Sean P Palecek

Open access · bronzeAbstract read
In one paragraph

Article in Cell chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Repositioning Antimicrobial Peptides Against WHO-Priority Fungi.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Specific Focus on Antifungal Peptides against Azole ResistantJournal of fungi (Basel, Switzerland) · 2022
    Review
  7. Review
  8. The Role ofPathogens (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Bacterial Quorum Sensing Signals Promote Large-Scale Remodeling of Lipid Membranes.Langmuir : the ACS journal of surfaces and colloids · 2021
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Bioactive Peptides Against Fungal Biofilms.Frontiers in microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Myung-Ryul LeeDepartment of Chemical and Biological Engineering, University of Wisconsin - Madison, Madison, WI 53706, USA.
Namrata RamanDepartment of Chemical and Biological Engineering, University of Wisconsin - Madison, Madison, WI 53706, USA.
Patricia Ortiz-BermúdezDepartment of Chemical Engineering, University of Puerto Rico, Mayagüez Campus, Mayagüez, Puerto Rico.
David M LynnDepartment of Chemical and Biological Engineering, University of Wisconsin - Madison, Madison, WI 53706, USA; Department of Chemistry, University of Wisconsin - Madison, Madison, WI 53706, USA. Electronic address: david.lynn@wisc.edu.
Sean P PalecekDepartment of Chemical and Biological Engineering, University of Wisconsin - Madison, Madison, WI 53706, USA. Electronic address: sppalecek@wisc.edu.
University of Wisconsin–Madison · USUniversity of Puerto Rico-Mayaguez · PR

Funding

Prevention of C. Albicans Biofilms by Beta-Peptide Release From Thin FilmsR01AI092225 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2011 to 2015
$1.8M
Prevention of Candida biofilms by localized delivery of aurein analoguesR33AI127442 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2019 to 2021
$1.4M
QExactive (Orbitrap) mass spectrometerS10OD020022 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI VESTLING, MARTHA M · 2015 to 2015
$483k
Prevention of Candida biofilms by localized delivery of aurein analoguesR21AI127442 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2017 to 2018
$421k
NIAID NIH HHS R01 AI092225NIAID NIH HHS R21 AI127442NIAID NIH HHS R33 AI127442NIH HHS S10 OD020022
6 · The paper itself

Abstract

Synthetic peptidomimetics of antimicrobial peptides (AMPs) are promising antimicrobial drug candidates because they promote membrane disruption and exhibit greater structural and proteolytic stability than natural AMPs. We previously reported selective antifungal 14-helical β-peptides, but the mechanism of antifungal toxicity of β-peptides remains unknown. To provide insight into the mechanism, we studied antifungal β-peptide binding to artificial membranes and living Candida albicans cells. We investigated the ability of β-peptides to interact with and permeate small unilamellar vesicle models of fungal membranes. The partition coefficient supported a pore-mediated mechanism characterized by the existence of a critical β-peptide concentration separating low- and high-partition coefficient regimes. Live cell intracellular tracking of β-peptides showed that β-peptides translocated into the cytoplasm, and then disrupted the nucleus and vacuole sequentially, leading to cell death. This understanding of the mechanisms of antifungal activity will facilitate design and development of peptidomimetic AMPs, including 14-helical β-peptides, for antifungal applications.

Indexed as

Antimicrobial Cationic PeptidesCandida albicansCell MembraneCell NucleusHydrophobic and Hydrophilic InteractionsMicrobial Sensitivity TestsProtein Conformation, alpha-HelicalTime-Lapse ImagingUnilamellar LiposomesAntimicrobial Cationic PeptidesUnilamellar Liposomes14-helical β-peptideantifungal β-peptideCandida albicansintracellular targetmechanism of antifungal peptidespartition coefficientspeptidomimeticssmall unilamellar vesicles

Identifiers

PMID30581136
PMCPMC6386598
OpenAlexW2952315077

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.